Glibenclamide MSDS
Glibenclamide MSDS
Glibenclamide MSDS
Glibenclamide:
OSHA Hazards: Target organ effect
Target Organs: Pancreas, Gastrointestinal tract
GHS Classification: Not a dangerous substance according to GHS
GHS Label elements, including precautionary statements
Pictogram: none
Signal word: none
Hazard statement(s): none
Precautionary statement(s): none
HMIS Classification
Health hazard: 0
Chronic health hazard: *
Flammability: 0
Physical hazards: 0
NFPA Rating
Health Hazard: 0
Fire: 0
Reactivity Hazard: 0
Potential Health Effects
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation.
Skin: May be harmful if absorbed through skin. May cause skin irritation.
Eyes: May cause eye irritation.
Ingestion: May be harmful if swallowed.
General advice: Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled: If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact: Wash off with soap and plenty of water.
In case of eye contact: Flush eyes with water as precaution.
If swallowed: Never give anything by mouth to an unconscious person. Rinse mouth with water.
5: FIRE-FIGHTING MEASURES
Personal precautions: Avoid dust formation. Avoid breathing vapors, mist, gas, or dust. Ensure adequate ventilation.
Environmental precautions: Do not let product enter drains.
PAGE 1 OF 3
MATERIAL SAFETY DATA SHEET
Cat# 1878-500, -1000, Glibenclamide MSDS DATE: Mar 27, 2012
Methods for cleaning up: Sweep up and shovel. Keep in suitable, closed containers for disposal.
Property Glibenclamide
Appearance: White to off-white solid
pH: No data available
Water Solubility: No data available
Other Solubility: DMSO (100 mM), EtOH (5 mM)
Specific Gravity (g/ml): No data available
Boiling Point (C): No data available
Melting Point (C): 173-175 oC (343-347 oF)
Flash Point (C): No data available
Ignition Temperature (C): No data available
Density No data available
Property Glibenclamide
Chemical stability Stable under recommended storage conditions
Conditions to avoid: No data available
Materials to avoid: Strong oxidizing agents
Hazardous decomposition products: Carbon oxides, nitrogen oxides, sulfur oxides,
hydrogen chloride gas
Glibenclamide:
Acute toxicity: LD50 Oral rat >20,000 mg/kg
Skin corrosion/irritation: no data available
Serious eye damage/eye irritation: no data available
Respiratory or skin sensitization: no data available
Germ cell mutagenicity: no data available
Carcinogenicity:
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or
confirmed human carcinogen by IARC.
ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential
carcinogen by ACGIH.
NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated
carcinogen by NTP.
OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential
carcinogen by OSHA.
Reproductive toxicity: Developmental toxicity rat subcutaneous Effects on embryo or fetus: fetal death.
PAGE 2 OF 3
MATERIAL SAFETY DATA SHEET
Cat# 1878-500, -1000, Glibenclamide MSDS DATE: Mar 27, 2012
Developmental toxicity rat subcutaneous Specific developmental abnormalities: eye, ear.
Reproductive toxicity rat Intraperitoneal Effects on newborn: viability index (e.g. # alive at day 4 per # born alive).
Teratogenicity: no data available
Aspiration hazard: no data available
Potential Health Effects
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation.
Skin: May be harmful if absorbed through skin. May cause skin irritation.
Eyes: May cause eye irritation.
Ingestion: May be harmful if swallowed.
Signs and Symptoms of Exposure: Exposure may cause hypoglycemia, gastrointestinal disturbance, central nervous system depression,
blood disorders, and/or circulatory collapse. To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Synergistic effects: no data available
Additional information: RTECS: YS4725200
Glibenclamide:
Persistence and degradability: no data available
Toxicity: no data available
Bioaccumulative potential: no data available
Mobility in soil: no data available
PBT and vPvB assessment: no data available
Other adverse effects: no data available
Glibenclamide:
DOT (US): Not dangerous goods.
IMDG: Not dangerous goods.
IATA: Not dangerous goods.
Glibenclamide:
OSHA Hazards: Target organ effect
DSL Status: All components of this product are on the Canadian DSL list.
SARA 302 Components: SARA 302: No chemical in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components: SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the
threshold (De Minimis) reporting levels established by SARA Title II, Section 313.
SARA 311/312 Hazards: Chronic Health Hazard
Massachusetts Right To Know Components: No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components: Glibenclamide, CAS-No. 10238-21-8
New Jersey Right To Know Components: Glibenclamide, CAS-No. 10238-21-8
California Prop. 65 Components: This product does not contain any chemicals known to State of California to cause cancer, birth defects, or
any other reproductive harm.
EU regulations
Component Risk Phrases Safety Phrases
Glibenclamide -- S24/25
DISCLAIMER:
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in
this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It
does not represent any guarantee of the properties of the product. BioVision, Inc., shall not be held liable for any damage resulting from
handling or from contact with the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale.
PAGE 3 OF 3